EC Pulmonology and Respiratory Medicine

We present a case of a 38-year-old male with one month of shortness of breath and fever after a recent plane trip. The patient was diagnosed with COVID-19 infection and was found to have associated submassive pulmonary embolism on a computed tomography scan with evidence of right heart strain. He was treated with catheter-directed lytic therapy, which resulted in rapid clearance of pulmonary embolism and significant improvement in shortness of breath. This case highlights the successful management of submassive pulmonary embolism using catheter-directed lytic therapy in the setting of an active COVID-19 infection.

 Keywords: Pulmonary Embolism; COVID-19; Catheter-Directed-Thrombolytic Therapy; Lytic Therapy; Submassive Pulmonary Embolism

1. Han Huan., et al. “Prominent changes in blood coagulation of patients with SARS-CoV-2 infection”. Clinical Chemistry and Laboratory Medicine7 (2020): 1116-1120.
2. Nguyen Phillip C., et al. “Submassive Pulmonary Embolism: Current Perspectives and Future Directions”. Journal of Clinical Medicine15 (2021): 3383.
3. Boira Ignacio., et al. “Major Bleeding Complications in COVID-19 Patients”. Cureus8 (2021): e16816.
4. Siordia Juan Arturo and Amanpreet Kaur. “Catheter-directed Thrombolysis versus Systemic Anticoagulation for Submassive Pulmonary Embolism: A Meta-Analysis”. Current Cardiology Reviews1 (2022): 112-117.
5. Owens Charles A. “Ultrasound-Enhanced Thrombolysis: EKOS EndoWave Infusion Catheter System”. Seminars in Interventional Radiology1 (2008): 37-41.
6. Francis CW., et al. “Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots”. Ultrasound in Medicine and Biology3 (1995): 419-424.
7. Siddiqi F., et al. “Binding of tissue-plasminogen activator to fibrin: effect of ultrasound”. Blood6 (1998): 2019-2025.
8. Kucher Nils., et al. “Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism”. Circulation4 (2014): 479-486.
9. Piazza Gregory., et al. “A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study”. JACC: Cardiovascular Interventions10 (2015): 1382-1392.
10. Tapson Victor F., et al. “A Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism: The OPTALYSE PE Trial”. JACC: Cardiovascular Interventions14 (2018): 1401-1410.
11. Kocas Betul Balaban and Kadriye Kilickesmez. “Catheter-directed thrombolysis in a COVID-19 patient complicated with pulmonary embolism”. Turkish Journal of Emergency Medicine1 (2022): 54-57.
12. Stein Paul D., et al. “Catheter-Directed Thrombolysis in Submassive Pulmonary Embolism and Acute Cor Pulmonale”. The American Journal of Cardiology 131 (2020): 109-114.
13. Gorgis Sarah., et al. “Ultrasound-assisted catheter-directed thrombolysis versus anticoagulation alone for management of submassive pulmonary embolism”. Journal of Cardiology5 (2022): 441-448.
14. Bloomer Tyler L., et al. “Safety of catheter-directed thrombolysis for massive and submassive pulmonary embolism: Results of a multicenter registry and meta-analysis”. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions4 (2017): 754-760.
15. Kline Theresa M., et al. “Ultrasound-assisted catheter-directed thrombolysis versus systemic anticoagulation alone for submassive pulmonary embolism”. Journal of Thrombosis and Thrombolysis1 (2021): 130-137.